Competitor Analysis: Enzyme Replacement Therapies

Date: January 1, 2013
Pages: 74
Price:
US$ 403.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C63978B5C24EN
Leaflet:

Download PDF Leaflet

Competitor Analysis: Enzyme Replacement Therapies
The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic insufficiency due to cystic fibrosis, pancreatitis and other causes.

Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of novel enzyme replacement & enhancement therapy products and an overview of approved products. In addition, the report lists company-specific product portfolios and R&D pipelines of enzyme replacement and enhancement therapies. Competitor projects are listed in a tabular format providing Information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
  • Gaucher Disease
  • Fabry Disease
  • PompĂ© Disease
  • Hunter Disease (MPS II)
  • Niemann Pick Diseases
  • Mucopolysaccharidosis I (MPS I)
  • San Filippo Syndrome (MPS IIIA)
  • Morquio Syndrome (MPS IVA)
  • Mucopolysaccharidosis VI (MPS VI)
  • Tay-Sachs Disease
  • Chronic Deficiency of Adenosine Deaminase
  • Phenylketonuria / Hyperphenylalaninemia
  • Other Enzyme Replacement Therapies
  • Exocrine Pancreatic Insufficiency: Porcine-Derived ERT
  • Exocrine Pancreatic Insufficiency: Recombinant ERT
  • Others
Skip to top


Ask Your Question

Competitor Analysis: Enzyme Replacement Therapies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: